Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alba L Montoya

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Plos Neglected Tropical Diseases|October 26, 2017
An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania majorEva Iniguez, Nathaniel S Schocker, Krishanthi Subramaniam, et al.
Emerging Microbes & Infections|August 30, 2022
Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteinsSayonara M Viana, Alba L Montoya, Augusto M Carvalho, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas DiseaseUriel Ortega-Rodriguez, Susana Portillo, Roger A Ashmus, et al.
Molecules (Basel, Switzerland)|September 9, 2022
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas DiseaseAlba L Montoya, Elisa G Carvajal, Uriel Ortega-Rodriguez, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Plos Neglected Tropical Diseases|October 26, 2017
An α-Gal-containing neoglycoprotein-based vaccine partially protects against murine cutaneous leishmaniasis caused by Leishmania majorEva Iniguez, Nathaniel S Schocker, Krishanthi Subramaniam, et al.
Emerging Microbes & Infections|August 30, 2022
Serodiagnosis and therapeutic monitoring of New-World tegumentary leishmaniasis using synthetic type-2 glycoinositolphospholipid-based neoglycoproteinsSayonara M Viana, Alba L Montoya, Augusto M Carvalho, et al.
Methods in Molecular Biology (Clifton, N.J.)|March 15, 2019
Purification of Glycosylphosphatidylinositol-Anchored Mucins from Trypanosoma cruzi Trypomastigotes and Synthesis of α-Gal-Containing Neoglycoproteins: Application as Biomarkers for Reliable Diagnosis and Early Assessment of Chemotherapeutic Outcomes of Chagas DiseaseUriel Ortega-Rodriguez, Susana Portillo, Roger A Ashmus, et al.
Molecules (Basel, Switzerland)|September 9, 2022
A Branched and Double Alpha-Gal-Bearing Synthetic Neoglycoprotein as a Biomarker for Chagas DiseaseAlba L Montoya, Elisa G Carvajal, Uriel Ortega-Rodriguez, et al.
Pageof 2